Actions
Washington
,
US
14 - 17 November 2026
Obesity Week (OW 2026)
Presentation schedule and materials
Saturday, 14 November 2026
19:30
- 20:30
EST
POSTER
Impact of Oral Semaglutide 25 mg on Patient-Reported Daily Activities: IWDAQ Outcomes from OASIS 4
Domenica Rubino1; Oscar Birkhan2; Silvia Gasparroni2; Lisa von Huth Smith2; Agnieszka Klimek-Abercrombie2; Megha Poddar3
MATERIALS AVAILABLE
Coming soon
19:30
EST
POSTER
Effect of CagriSema according to baseline BMI and obesity-related complications: REDEFINE 1 trial
W. Timothy Garvey1; Jaime P. Almandoz2; Mikkel Hovden Christensen3; Tobias Freyberg Justesen3; Domenica Rubino4; Kirsi H. Pietiläinen5; Arya M. Sharma6; Kasper Adelborg3; John P.H. Wilding7
MATERIALS AVAILABLE
Coming soon
19:30
- 20:30
EST
POSTER
Impact of cagrilintide 2.4 mg on cardiometabolic risk indicators: A post-hoc analysis of REDEFINE 1
W. Timothy Garvey1; Rikke Mortensen Abschneider2; Morten Böttcher3; Dana Li2; Kasper Adelborg2; John Wilding4; Ildiko Lingvay5
MATERIALS AVAILABLE
Coming soon
19:30
- 20:30
EST
443
POSTER
3-Month Food Noise and Patient-Reported Outcomes With Oral Semaglutide for Overweight or Obesity
Victoria Divino1; Brooke J. Smith2; Lauren Wilson1; Lauren Broffman2; Camilla S. Morgen3; Jigish Bhavsar1; Raoul Manalac2; Rina Patel1; Sam Chai2; Louis J. Aronne4; Beverly G. Tchang4
MATERIALS AVAILABLE
Coming soon
19:30
- 20:30
EST
234
POSTER
Real-World Clinical Outcomes with Semaglutide in a Population with Overweight or Class I Obesity
Domenica Rubino1; Julia Wang2; Lauren Wilson2; Wojciech Michalak2; Susan Alford2; Francisco Lopez-Jimenez3
MATERIALS AVAILABLE
Coming soon
19:30
- 15:30
EST
POSTER
The predicted impact of CagriSema for the primary prevention of cardiovascular disease in the US population with overweight or obesity
Morten Bøttcher1; Tina Landsvig Berentzen2; Benjamin D Bray3; Christa Broholm2; Martin Bøg2; Mattia Ficarelli3; Julie Hviid Hahn-Pedersen2; Salman Ramjaun3; Soeren Mattke4
MATERIALS AVAILABLE
Coming soon
19:30
- 20:30
EST
ORAL PRESENTATION
Efficacy and safety of co-administered cagrilintide-semaglutide (CagriSema) 1.7 mg each and 1.0 mg each in adults with overweight or obesity (REDEFINE 9): a multicentre, randomised, double-blind within-dose-level, placebo-controlled, parallel-group, phase 3b trial
Sean Wharton1,2; Christa Broholm3; Deborah Horn5; Alexandru Remus Pinta3, 4; Domenica Rubino6; Zara Rebecca Broholm3; Stephen C Bain7
MATERIALS AVAILABLE
Coming soon
Sunday, 15 November 2026
02:30
- 03:30
EST
587
POSTER
Obesity medication preferences among younger and older adults: an age-stratified analysis
Sara Tadesse Bell1; Jaime P. Almandoz2; Cannon Kent3; Jigish Bhavsar1; Victoria Divino1; María Quiroga4; Andrea Traina1; Kelley Myers3
MATERIALS AVAILABLE
Coming soon
02:30
- 03:30
EST
586
POSTER
Preferences for obesity medications among health care professionals
Victoria Divino1; Jaime P. Almandoz2; Beverly G. Tchang3; Jigish Bhavsar1; Sara Tadesse Bell1; María Quiroga4; Kelley Myers5; Cannon Kent5; Andrea Traina1
MATERIALS AVAILABLE
Coming soon
02:30
- 03:30
EST
511
POSTER
Characteristics of Early Initiators of Oral Semaglutide for Overweight or Obesity via Telehealth
Brooke J. Smith1; Victoria Divino2; Camilla S. Morgen3; Lauren Broffman1; Lauren Wilson2; Raoul Manalac1; Rakesh Luthra2; Rina Patel2; Sam Chai1; Louis J. Aronne4; Beverly G. Tchang4
MATERIALS AVAILABLE
Coming soon
02:30
- 03:30
EST
546
POSTER
3-Month Weight Outcomes with Oral Semaglutide via Telehealth in Adults with Overweight or Obesity
Lauren Broffman1; Victoria Divino2; Lauren Wilson2; Brooke J. Smith1; Camilla S. Morgen3; Raoul Manalac1; Rakesh Luthra2; Rina Patel2; Sam Chai1; Louis J. Aronne4; Beverly G. Tchang4
MATERIALS AVAILABLE
Coming soon
02:30
- 03:30
EST
454
POSTER
Changes in Food Noise and Weight with Semaglutide Injection for Weight Management via Telehealth
Victoria Divino1; Lauren Broffman2; Brooke J. Smith2; Rakesh Luthra1; Rina Patel1; Raoul Manalac2; Sam Chai2; Louis J. Aronne3; Beverly G. Tchang3
MATERIALS AVAILABLE
Coming soon
02:30
- 03:30
EST
2266292
POSTER
Real-World Weight Outcomes and Patient Experience with Oral Semaglutide in a Digital Support Cohort
Jessica Muth 1; Wojciech Michalak 1; Carmen Ng 1; Sara Tadesse Bell 1; Angela Fitch 2
MATERIALS AVAILABLE
Coming soon
08:30
- 08:45
EST
ORAL PRESENTATION
Effects of CagriSema on physical and psychosocial function in overweight or obesity: REDEFINE 1
Domenica Rubino1; Kirsi H. Pietiläinen2; Arya M. Sharma3; Subodh Verma4; Sean Wharton5; Julie Hviid Hahn-Pedersen6; Tobias Freyberg Justesen6; Lisa von Huth Smith6; Christian Bøge Lyndgaard6; Ronette L. Kolotkin7-10
MATERIALS AVAILABLE
Coming soon
14:30
- 15:30
EST
POSTER
Cagrilintide’s Potential Benefits on Bone Health via Proteomics in Adults With Over-Weight or Obesity
Anne-Mette Bjerregaard1; Jonas Andreas Sibbesen1; Kristian Ebbesen Hanghøj1; Marco Ponzetti2; Dana Li3; Christoffer Andersen Hagemann3; Anna Secher2; Kirsten Raun2; David Højland Ipsen2
MATERIALS AVAILABLE
Coming soon
14:30
- 15:30
EST
POSTER
Early response and weight loss trajectories with CagriSema in overweight or obesity: REDEFINE 1
W. Timothy Garvey1; Kirsi H. Pietiläinen2; Jaime Almandoz3; Mikkel Hovden Christensen4; Cynthia Karenina Osorto Contreras4; Thomas Bo Jensen4; Michael G. Knight5; Ricardo Arturo Reynoso Mendoza6; Carel W. le Roux7,8
MATERIALS AVAILABLE
Coming soon
14:30
EST
POSTER
REDEFINE 9: Effect of CagriSema 1.7 mg/1.7 mg and 1.0 mg/1.0 mg in Adults With Overweight or Obesity
Sean Wharton1,2; Christa Broholm3; Deborah Horn4; Alexandru-Remus Pinţa3; Domenica Rubino5; Zara Rebecca Broholm3; Stephen Bain6;
MATERIALS AVAILABLE
Coming soon
14:30
- 15:30
EST
POSTER
AWS Cloud–First Data Discovery for Pragmatic Clinical Trial Linkage
Thomas Dougherty1; Helene Nordahl1; Matt Witman2; Anala Gossai2; Kathleen M. Gavin2
MATERIALS AVAILABLE
Coming soon
16:00
- 16:15
EST
ORAL PRESENTATION
Effect of Cagrilintide 2.4 mg on food cravings and eating behavior: REDEFINE 1 post hoc analysis
Michelle Dalton1; Rikke M. Abschneider2; Thomas L. Holm2; Dana Li2; Kirsi H. Pietiläinen3; Domenica Rubino4; Thomas Wadden5; Matthias Blüher6
MATERIALS AVAILABLE
Coming soon
18:30
- 19:45
EST
Symposium
Obesity in Focus: Today's evidence. Tomorrow's possibilities
Jaime Almandoz
;
Deborah Bade Horn
;
Akshay Jain
;
Thomas Lutz
;
Domenica Rubino
MATERIALS AVAILABLE
Monday, 16 November 2026
02:30
- 03:30
EST
POSTER
Physical and Psychosocial Improvement With CagriSema in REDEFINE 1: Item-Level IWQOL-Lite-CT Outcomes
Domenica Rubino 1; Subodh Verma 2 ; Kirsi H. Pietiläinen 3,4 ; Arya M. Sharma 5 ; Sean Wharton 6 ; Julie Hviid Hahn-Pedersen 7 ; Tobias Freyberg Justesen 7 ; Lisa von Huth Smith 7 ; Christian Bøge Lyndgaard 7 ; Ronette L. Kolotkin 8-11
MATERIALS AVAILABLE
Coming soon
Actions
Keywords